|
|
|
|
|
|||
|
|
|||
|
|
|||
|
|||
|
Molecular Rationale for the Pharmacological Treatment of Alzheimer's Disease |
Fundamentos Moleculares para el Tratamiento Farmacológico de la Enfermedad de Alzheimer |
||
|
Enfermedad de Alzheimer, Proteina precursora de amiloide, Amiloide beta, Inmunoterapia |
Alzheimer's disease, Amyloid precursor protein, Amyloid beta peptide, Inmmunotherapy |
||
|
Zimmermann M, Gardoni F, Di Luca M |
M Di Luca, Centre of Excellence on Neurodegenerative Diseases and Department of Pharmacological Treatment of Alzheimer's Disease 20133 Milan Italia |
||
|
Los autores no manifiestan conflictos de interés |
|||
|
Centre of Excellence on Neurodegenerative Diseases and Department of Pharmacological Treatment of Alzheimer's Disease |
|||
|
ReSIIC editado en las
especialidades: |
|||
|
|
|
|
|
Sociedad Iberoamericana de Información Científica (SIIC)
|